China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
In summary, the CHILLAS study will be the first multicenter study performed in a Chinese
population using a patient-level analysis to compare the effects and safety of intensive
statin therapy with that of moderate statin therapy. Therefore, it will determine whether
"lower is better", that is, whether LDL cholesterol lowering to a level of approximately
100mg/dl provides a benefit inferior to that of LDL cholesterol lowering to a much lower
level; examine the role of inflammatory markers in predicting cardiac events and response to
statin therapy; and evaluate the effects of statin therapy on regression of coronary
atherosclerosis using IVUS.
Phase:
N/A
Details
Lead Sponsor:
Ministry of Science and Technology of the People´s Republic of China